Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.48 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.48 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.43 |
| ▸ | MME | P08473 | 2/20 | 0.42 |
| ▸ | GNPAT | O15228 | 1/20 | 0.42 |
| ▸ | BACE1 | P56817 | 5/20 | 0.41 |
| ▸ | CTSD | P07339 | 1/20 | 0.41 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.39 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31181173 | 0.91 | ENPEP (0.44) | ENPEPGNPATBACE1CTSDBACE2 | |
| SCHEMBL31721055 | 0.90 | PDCD1LG2 (0.60) | PDCD1LG2CD274BACE1CTSD | |
| SCHEMBL29633667 | 0.89 | PDCD1LG2 (0.45) | PDCD1LG2CD274MMEBACE1CTSD | |
| SCHEMBL30199868 | 0.89 | BACE1 (0.44) | PDCD1LG2CD274ENPEPBACE1CTSD | |
| SCHEMBL12436724 | 0.88 | BACE1 (0.49) | ENPEPMMEBACE1CTSDBACE2 | |
| SCHEMBL29777795 | 0.87 | PDCD1LG2 (0.47) | PDCD1LG2CD274MME | |
| SCHEMBL16870893 | 0.87 | PDCD1LG2 (0.47) | PDCD1LG2CD274MME | |
| SCHEMBL29531582 | 0.87 | PDCD1LG2 (0.47) | PDCD1LG2CD274MME | |
| SCHEMBL31181278 | 0.87 | BACE1 (0.53) | ENPEPGNPATBACE1CTSDBACE2 | |
| SCHEMBL29350673 | 0.87 | BACE1 (0.47) | ENPEPMMEBACE1CTSDBACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250115640-A1 | NEUROPROTECTIVE POLYPEPTIDE COMPOUND AND APPLICATION THEREOF | INNERSE (ZHUHAI) PHARMACEUTICAL CO., LTD. (CN) | 2025-04-10 | — | — | US | claimed |
| EP-3505533-B1 | SYNTHESIS METHOD FOR LOW-RACEMIZATION IMPURITY LIRAGLUTIDE | SHENZHEN JYMED TECH CO LTD (CN) | 2025-01-15 | — | — | EP | claimed |
| US-11518794-B2 | Synthesis method for liraglutide with low racemate impurity | Shenzhen JYMed Technology Co., Ltd. (CN) | 2022-12-06 | — | — | US | claimed |
| EP-4736958-A2 | ANTI-5T4 ANTIBODIES AND USES THEREOF | Lepu Biopharma Co., Ltd. (CN) | 2026-05-06 | — | — | EP | disclosed |
| US-20250154277-A1 | ANTI-5T4 ANTIBODIES AND USES THEREOF | Lepu Biopharma Co., Ltd. (CN) | 2025-05-15 | — | — | US | disclosed |
| US-20250115640-A1 | NEUROPROTECTIVE POLYPEPTIDE COMPOUND AND APPLICATION THEREOF | INNERSE (ZHUHAI) PHARMACEUTICAL CO., LTD. (CN) | 2025-04-10 | — | — | US | disclosed |
| EP-3505533-B1 | SYNTHESIS METHOD FOR LOW-RACEMIZATION IMPURITY LIRAGLUTIDE | SHENZHEN JYMED TECH CO LTD (CN) | 2025-01-15 | — | — | EP | disclosed |
| EP-4482876-A1 | ANTI-5T4 ANTIBODIES AND USES THEREOF | Concept to Medicine Biotech Co., Ltd. (CN) | 2025-01-01 | — | — | EP | disclosed |
| CN-118946590-A | Anti-5T 4 antibodies and uses thereof | 乐普创一生物科技（上海）有限公司 | 2024-11-12 | — | — | CN | disclosed |
| WO-2023155925-A1 | ANTI-5T4 ANTIBODIES AND USES THEREOF | CONCEPT TO MEDICINE BIOTECH CO., LTD. (CN) | 2023-08-24 | — | — | WO | disclosed |
| US-11518794-B2 | Synthesis method for liraglutide with low racemate impurity | Shenzhen JYMed Technology Co., Ltd. (CN) | 2022-12-06 | — | — | US | disclosed |